ElevenLabs launched Music v2.5 on September 11, 2026. The model is now the default "for prompted and reference generation" inside ElevenMusic, the company's music generation product. The release came shortly after ElevenLabs announced a licensing deal with Universal Music Group, one of the three major labels controlling the largest share of global recorded music catalogue.
The order of events is the part worth studying. A licensing agreement first, then a model update that makes reference-based generation the default. That sequence tells you where the commercial terms were pointed: reference audio, meaning existing recordings used as input to steer new generations, is now core to the product rather than a side feature.
Why this touches catalogue valuation
Catalogue valuation has traditionally relied on streaming royalty history, sync licensing income, and comparable sales multiples. A UMG licensing deal with a generative AI platform adds a new input: reference-use rights. If a catalogue can be licensed for AI training or reference generation, that catalogue has a revenue stream that did not exist eighteen months ago, and it needs its own pricing logic.
For independent artists and boutique labels without UMG-scale negotiating use, the immediate risk is not competition from AI-generated tracks. It is that their catalogues get valued using outdated assumptions while major-label catalogues are already being repriced around AI licensing terms they cannot see.
What royalty aggregators should be watching
- Deal structure:Whether UMG's agreement with ElevenLabs is a flat license, a revenue share, or a hybrid, and whether that structure becomes the template other labels and distributors adopt.
- Reporting lag:AI-sourced reference-use income will likely appear in royalty statements months after the underlying deal, which means valuation models built on trailing twelve-month data will understate catalogue value in the near term.
- Model versioning as a signal:Music v2.5 shipping days after the UMG announcement suggests ElevenLabs is moving quickly from licensing agreement to product deployment. Aggregators tracking similar deals with Sony Music, Warner Music Group, or independent distributors should expect the same short gap between announcement and live product.
The practical takeaway
A catalogue valuation model that only accounts for streaming and sync revenue is missing a category that a major label just validated with a signed deal. Independent artists and boutique labels should ask their aggregators and advisors whether reference-use and AI licensing rights are being priced into their catalogue at all, and if not, when that will change.
